Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 2/2015

01-04-2015 | Case Report

Microwave Ablation (MWA) for the Treatment of a Solitary, Chemorefractory Testicular Cancer Liver Metastasis

Authors: Elena G. Violari, Elena N. Petre, Darren R. Feldman, Joseph P. Erinjeri, Karen T. Brown, Stephen B. Solomon, Michael I. D’Angelica, Constantinos T. Sofocleous

Published in: CardioVascular and Interventional Radiology | Issue 2/2015

Login to get access

Abstract

We present a case of a patient with stage IIIC metastatic seminoma with a persistent chemorefractory liver lesion. The patient was deemed a poor surgical candidate due to the tumor’s aggressive biology with numerous other liver lesions treated with chemotherapy and a relatively high probability for additional recurrences. Further chemotherapy with curative intent was not a feasible option due to the fact that the patient had already received second-line high-dose chemotherapy and four cycles of third-line treatment complicated by renal failure, refractory thrombocytopenia, and debilitating neuropathy. After initial failure of laser, microwave ablation of the chemorefractory liver metastasis resulted in prolonged local tumor control and rendered the patient disease-free for more than 35 months, allowing him to regain an improved quality of life.
Literature
1.
Einhorn LH (1981) Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 41(9 Pt 1):3275–3280PubMed
2.
Einhorn LH, Donohue J (2002) Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997. J Urol 167(2 Pt 2):928–932 discussion 933CrossRefPubMed
3.
de Wit R, Stoter G, Sleijfer DT et al (1995) Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J Cancer 71(6):1311–1314CrossRefPubMedCentralPubMed
4.
Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316(23):1435–1440CrossRefPubMed
5.
Feldman DR, Bosl GJ, Sheinfeld J et al (2008) Medical treatment of advanced testicular cancer. JAMA 299(6):672–684CrossRefPubMed
6.
Feldman DR, Sheinfeld J, Bajorin DF et al (2010) TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. J Clin Oncol 28(10):1706–1713CrossRefPubMedCentralPubMed
7.
Ryan ER, Sofocleous CT, Schoder H et al (2013) Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 268(1):288–295CrossRefPubMedCentralPubMed
8.
Biggs ML, Schwartz SM (2004) Differences in testis cancer survival by race and ethnicity: a population-based study, 1973–1999 (United States). Cancer Causes Control 15(5):437–444CrossRefPubMed
9.
Lorch A, Bascoul-Mollevi C, Kramar A et al (2011) Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol 29(16):2178–2184CrossRefPubMed
10.
Mosharafa AA, Foster RS, Leibovich BC et al (2003) Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 169(6):2126–2128CrossRefPubMed
11.
Warde P, Specht L, Horwich A et al (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20(22):4448–4452CrossRefPubMed
12.
Jones WG, Fossa SD, Mead GM et al (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23(6):1200–1208CrossRefPubMed
13.
Goulet RJ Jr, Hardacre JM, Einhorn LH et al (1990) Hepatic resection for disseminated germ cell carcinoma. Ann Surg 212(3):290–293 discussion 293-294CrossRefPubMedCentralPubMed
14.
Eastham JA, Wilson TG, Russell C et al (1994) Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43(1):74–80CrossRefPubMed
15.
Sideras PA, Sofocleous CT, Brody LA et al (2012) Superselective internal radiation with yttrium-90 microspheres in the management of a chemorefractory testicular liver metastasis. Cardiovasc Intervent Radiol 35(2):426–429CrossRefPubMed
16.
Sofocleous CT, Petre EN, Gonen M et al (2011) CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 22(6):755–761CrossRefPubMedCentralPubMed
17.
Sofocleous CT, Petre EN, Gonen M et al (2014) Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases. J Vasc Interv Radiol 25(1):22–30CrossRefPubMed
18.
Maluccio MA, Covey AM, Schubert J et al (2006) Treatment of metastatic sarcoma to the liver with bland embolization. Cancer 107(7):1617–1623CrossRefPubMed
19.
Hong K, McBride JD, Georgiades CS et al (2009) Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol 20(3):360–367CrossRefPubMed
20.
Livraghi T, Solbiati L, Meloni F et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 97(12):3027–3035CrossRefPubMed
21.
Livraghi T, Meloni F, Solbiati L et al (2012) Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol 35(4):868–874CrossRefPubMed
22.
de Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175(6):1619–1625CrossRefPubMed
23.
Solbiati L, Ahmed M, Cova L et al (2012) Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 265(3):958–968CrossRefPubMed
24.
Wright AS, Sampson LA, Warner TF et al (2005) Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236(1):132–139CrossRefPubMed
25.
Wang X, Sofocleous CT, Erinjeri JP et al (2013) Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 36(1):166–175CrossRefPubMedCentralPubMed
26.
Brown KT, Nevins AB, Getrajdman GI et al (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9(5):822–828CrossRefPubMed
Metadata
Title
Microwave Ablation (MWA) for the Treatment of a Solitary, Chemorefractory Testicular Cancer Liver Metastasis
Authors
Elena G. Violari
Elena N. Petre
Darren R. Feldman
Joseph P. Erinjeri
Karen T. Brown
Stephen B. Solomon
Michael I. D’Angelica
Constantinos T. Sofocleous
Publication date
01-04-2015
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 2/2015
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-014-0924-z

Other articles of this Issue 2/2015

CardioVascular and Interventional Radiology 2/2015 Go to the issue

Clinical Investigation

Percutaneous Radiofrequency Ablation of Lung Cancer Presenting as Ground-Glass Opacity

Letter to the Editor

Spleen: Promised Land for New and Novel Interventions?

Clinical Investigation

Outcome Following a Negative CT Angiogram for Gastrointestinal Hemorrhage

Laboratory Investigation

Sphere-Enhanced Microwave Ablation (sMWA) Versus Bland Microwave Ablation (bMWA): Technical Parameters, Specific CT 3D Rendering and Histopathology

Technical Note

Radiation Protection Methods for the Interventionalist’s Hands: Use of an Extension Tube

Clinical Investigation

Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma